United States · Hotels · Condotels
Hotel Investment Screening for US Deals — Know Before You Wire
Independent five-layer due diligence on $10M+ hotel and condotel investments across the United States. Red flags in days — before your capital is committed. Human verdict, AI engine.
Request a red flag scanThe framework
Five layers, weighted
20%
Market
Demand drivers, supply pipeline, competitive set positioning and how the hotel actually performs against it.
30%
Financials
The P&L behind the asking price: revenue quality, cost normalization, fees and the cash that truly reaches the owner.
20%
Asset Condition
Physical state, deferred capital, brand standards and the realistic capex the next owner inherits.
10%
Legal
Title, management and franchise agreements, zoning and the obligations that transfer with the deal.
20%
Returns
Whether the price, financing and business plan produce returns that justify the risk.
Possible verdicts: Acquire · Conditional Acquire · Further Due Diligence · Decline.
Every deal exits with one defensible answer, issued by a human reviewer — never by software.
Three ways to engage
Decision Card
$7,500 (illustrative)
$10–18M deals · 5-day turnaround
Full Underwrite + IC Memo
$25,000 (illustrative)
$19–30M deals · 2–3 weeks
Retained Screening Desk
Custom retainer
$30M+ deals · Ongoing
Fee figures are illustrative; final scope is quoted per deal.
Start with a 30-minute red flag scan — gated, one per prospect, $10M+ deals. We surface the red flags; the verdict stays human.
Request a red flag scanQuestions
What size of US hotel deal do you screen?
We focus on hotel and condotel investments of $10M and up.
Does the AI decide whether I should buy?
No. AI accelerates the review; a human reviewer interprets the findings and issues the verdict.
What does the red flag scan include?
A 30-minute scan that surfaces red flags in your deal documents. It does not give a verdict. It is gated, one per prospect, for $10M+ deals.
Is this investment advice?
No. Our work is a diagnostic reference to support your own decision and your advisers.
Diagnostic reference only — not investment advice.